On Air Now

Current Show

Jerry Bader   8:30 AM - 11:00 AM

Text "JBSHOW" to 79489 and get updates from me. Email me at: jerrybadershow@mwcradio.com

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1360 AM Northeast, WI 97.5 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
66° Feels Like: 66°
Wind: S 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Mostly Sunny 77°

Tonight

Partly Cloudy 58°

Tomorrow

PM Thunderstorms 78°

Alerts

India's Ranbaxy falls on media report of U.S. FDA query on plant

A general view of the office of Ranbaxy Laboratories is pictured at Gurgaon, on the outskirts of New Delhi, June 13, 2013. REUTERS/Adnan Abi
A general view of the office of Ranbaxy Laboratories is pictured at Gurgaon, on the outskirts of New Delhi, June 13, 2013. REUTERS/Adnan Abi

MUMBAI (Reuters) - Shares of Ranbaxy Laboratories Ltd fell as much as 2.3 percent on Monday after newspaper Business Standard reported the U.S. Food and Drug Administration had raised concerns about a plant in northern India, citing unidentified sources.

Business Standard said the FDA had issued form 483 to Ranbaxy regarding its Mohali plant. That form is issued when U.S. inspectors see conditions they believe may violate U.S. rules.

A Ranbaxy spokesman declined to comment when asked if the drug maker had received the 483 form.

"We continue to make regulatory submissions from Mohali and will commercialize products from Mohali when we get approvals," he said.

The U.S. FDA was not immediately reachable for comment.

Ranbaxy shares were down 1.8 percent at 0355 GMT (11.55 p.m. EDT Sunday), compared with a 0.7 percent fall in the broader NSE index.

(Reporting by Kaustubh Kulkarni and Rafael Nam; Editing by Michael Urquhart)

Comments